Market Research Logo

Cell Surface Markers Market by Product (Antibody, PCR Array), Source (Mice, Rat), Cell Type (T cells, B cells, NK cell), Application (Research (Stem Cell, Immunology), Clinical (Oncology, Hematology)), and End User (Hospitals) - Global Forecast to 2023

Cell Surface Markers Market by Product (Antibody, PCR Array), Source (Mice, Rat), Cell Type (T cells, B cells, NK cell), Application (Research (Stem Cell, Immunology), Clinical (Oncology, Hematology)), and End User (Hospitals) - Global Forecast to 2023

“High global prevalence of cancer is expected to drive the overall growth of the cell surface markers market”
The cell surface markers market is projected to reach USD 769 million by 2023 from USD 520 million in 2018, at a CAGR of 8.1% during the forecast period. The growth of this market is majorly driven by the high global prevalence of cancer, increasing funding for life sciences research, and growth in stem cell and neurobiology research. On the other hand, factors such as the costly and time-intensive antibody development process may hinder the growth of this market in the coming years.

“Antibodies segment is expected to grow at the highest CAGR during the forecast period”
Based on product type, the cell surface markers market is segmented into antibodies and PCR arrays. The antibodies segment is expected to account for a larger share of the market in 2018 as well as grow at a higher CAGR during the forecast period. This can majorly be attributed to the increasing demand for accurate and reliable antibodies by research communities.

“T cell surface markers segment is expected to account for the largest share of the cell surface markers market, by cell type, during the forecast period”
Based on cell type, the cell surface markers market is segmented into T cell surface markers, B cell surface markers, NK cell surface markers, monocyte cell surface markers, and other cell types. In 2018, the T cell surface markers segment is expected to account for the largest share of the cell surface markers market. The large share of this segment is attributed to the high and growing use of T cell surface markers in research and diagnostics.

“North America to dominate the market during the forecast period”
In 2018, North America is expected to account for the largest share of the cell surface markers market. North America has a well-established pharmaceuticals sector and currently dominates the cell surface markers market due to the increasing demand for the effective diagnosis and treatment of chronic diseases. Also, the adoption rate of cell surface markers for disease diagnostics, majorly for cancer diagnosis, is high in North America. This is one of the major factors supporting the growth of this regional market. The Asian market, on the other hand, is expected to grow at the highest CAGR during the forecast period. Factors such as government initiatives to boost biotechnology and pharmaceutical industries and increasing life sciences research activities are supporting the growth of the cell surface markers market in Asia.


The primary interviews conducted for this report can be categorized as follows:
By Company Type - Tier 1: 55%, Tier 2: 20%, Tier 3: 25%
By Designation - C-level: 58%, D-level: 19%, Others: 23%
By Region - North America: 40%, Europe: 30%, Asia: 10%, RoW: 20%

List of Companies Profiled in the Report
Thermo Fisher Scientific (US)
QIAGEN N.V. (Netherlands)
Becton, Dickinson and Company (US)
F. Hoffman-La Roche (Switzerland)
Bio-Rad Laboratories (US)
Danaher Corporation (US)
Abcam (UK)
Genscript (China)
Biolegend (US)
B. Braun Melsungen AG (Germany)
Cell Signaling Technology (US)
Merck KGaA (Germany)
Bio-Techne (US)

Research Coverage:
This report provides a detailed picture of the global cell surface markers market. It aims at estimating the size and future growth potential of the market across different segments, such as product type, antibodies by source, cell type, application, end user, and region. The report also includes an in-depth competitive analysis of key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them the closest approximations of the revenue numbers for the overall cell surface markers market and its subsegments. Also, this report will help stakeholders to better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKET COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DESIGN
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • CELL SURFACE MARKERS: MARKET OVERVIEW
    • CELL SURFACE MARKERS MARKET, BY PRODUCT
    • CELL SURFACE MARKERS MARKET, BY CELL TYPE (2018)
    • CELL SURFACE MARKERS MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
    • CELL SURFACE MARKERS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
    • CELL SURFACE MARKERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table GLOBAL CANCER INCIDENCE, 2018 VS. 2025
      • RESTRAINTS
      • OPPORTUNITIES
  • CELL SURFACE MARKERS MARKET, BY PRODUCT
    • INTRODUCTION
      • Table CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
    • ANTIBODIES
      • ANTIBODIES TO DOMINATE THE CELL SURFACE MARKER PRODUCTS MARKET DURING THE FORECAST PERIOD
        • Table CELL SURFACE MARKER ANTIBODIES MARKET, BY REGION, 2016–2023 (USD MILLION)
    • PCR ARRAYS
      • PCR ARRAY PROFILES THE EXPRESSION OF GENES RELEVANT TO RESEARCH AT THE CELL SURFACE MARKER LEVEL
        • Table CELL SURFACE MARKER PCR ARRAYS MARKET, BY REGION, 2016–2023 (USD MILLION)
  • CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE
    • INTRODUCTION
      • Table CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
    • MICE
      • MICE ARE THE MOST PREFERRED HOSTS FOR RESEARCH-USE CELL SURFACE ANTIBODY PRODUCTION
        • Table CELL SURFACE MARKER ANTIBODIES MARKET FOR MICE, BY REGION, 2016–2023 (USD MILLION)
    • RATS
      • RATS ARE THE SECOND-MOST-WIDELY USED ANIMAL HOSTS FOR MONOCLONAL ANTIBODY PRODUCTION
        • Table CELL SURFACE MARKER ANTIBODIES MARKET FOR RATS, BY REGION, 2016–2023 (USD MILLION)
    • OTHER SOURCES
      • Table CELL SURFACE MARKER ANTIBODIES MARKET FOR OTHER SOURCES, BY REGION, 2016–2023 (USD MILLION)
  • CELL SURFACE MARKERS MARKET, BY CELL TYPE
    • INTRODUCTION
      • Table CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
    • T CELL SURFACE MARKERS
      • T CELL SURFACE MARKERS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2018
        • Table T CELL SURFACE MARKERS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • B CELL SURFACE MARKERS
      • B CELL SURFACE MARKERS ARE USED TO IDENTIFY B CELLS FROM HETEROGENEOUS SAMPLES
        • Table B CELL SURFACE MARKERS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • NK CELL SURFACE MARKERS
      • NK CELL SURFACE MARKERS IDENTIFY NK CELLS AT VARIOUS STAGES OF DEVELOPMENT
        • Table NK CELL SURFACE MARKERS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • MONOCYTE CELL SURFACE MARKERS
      • MONOCYTES PLAY A CRITICAL ROLE IN MAINTAINING OVERALL HEALTH
        • Table MONOCYTE CELL SURFACE MARKERS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • OTHER CELL TYPES
      • Table CELL SURFACE MARKERS MARKET FOR OTHER CELL TYPES, BY REGION, 2016–2023 (USD MILLION)
  • CELL SURFACE MARKERS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
    • RESEARCH APPLICATIONS
      • Table CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
      • Table CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
      • DRUG DISCOVERY
        • Table CELL SURFACE MARKERS MARKET FOR DRUG DISCOVERY, BY REGION, 2016–2023 (USD MILLION)
      • IMMUNOLOGY
        • Table CELL SURFACE MARKERS MARKET FOR IMMUNOLOGY, BY REGION, 2016–2023 (USD MILLION)
      • STEM CELL RESEARCH
        • Table CELL SURFACE MARKERS MARKET FOR STEM CELL RESEARCH, BY REGION, 2016–2023 (USD MILLION)
      • OTHER RESEARCH APPLICATIONS
        • Table CELL SURFACE MARKERS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
    • CLINICAL APPLICATIONS
      • Table CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
      • Table CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
      • ONCOLOGY
        • Table CELL SURFACE MARKERS MARKET FOR ONCOLOGY, BY REGION, 2016–2023 (USD MILLION)
      • IMMUNODEFICIENCY DISEASES
        • Table CELL SURFACE MARKERS MARKET FOR IMMUNODEFICIENCY DISEASES, BY REGION, 2016–2023 (USD MILLION)
      • OTHER CLINICAL APPLICATIONS
        • Table CELL SURFACE MARKERS MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
  • CELL SURFACE MARKERS MARKET, BY END USER
    • INTRODUCTION
      • Table CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
    • ACADEMIC & RESEARCH INSTITUTES
      • ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS OF THE CELL SURFACE MARKERS MARKET
        • Table CELL SURFACE MARKERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2016–2023 (USD MILLION)
    • HOSPITALS & CLINICAL TESTING LABORATORIES
      • HOSPITALS & CLINICAL TESTING LABORATORIES USE CELL SURFACE MARKERS FOR THE DIAGNOSIS OF VARIOUS DISEASES
        • Table CELL SURFACE MARKERS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2016–2023 (USD MILLION)
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
      • PATENT EXPIRATION OF BLOCKBUSTER DRUGS TO DRIVE THE GROWTH OF THE CELL MARKERS MARKET FOR THIS END-USER SEGMENT
        • Table CELL SURFACE MARKERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2023 (USD MILLION)
  • CELL SURFACE MARKERS MARKET, BY REGION
    • INTRODUCTION
      • Table CELL SURFACE MARKERS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • US
        • Table US: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table US: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table US: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
        • Table US: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table US: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • CANADA
        • Table CANADA: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table CANADA: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table CANADA: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
        • Table CANADA: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table CANADA: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
    • EUROPE
      • Table EUROPE: CELL SURFACE MARKERS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table EUROPE: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
      • Table EUROPE: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
      • Table EUROPE: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • Table EUROPE: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
      • Table EUROPE: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • GERMANY
        • Table GERMANY: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table GERMANY: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table GERMANY: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
        • Table GERMANY: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table GERMANY: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • FRANCE
        • Table FRANCE: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table FRANCE: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table FRANCE: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
        • Table FRANCE: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table FRANCE: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • UK
        • Table UK: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table UK: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table UK: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
        • Table UK: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table UK: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • ROE
        • Table ROE: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
        • Table ROE: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
        • Table ROE: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
        • Table ROE: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table ROE: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
    • ASIA
      • Table ASIA: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
      • Table ASIA: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
      • Table ASIA: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
      • Table ASIA: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • Table ASIA: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
      • Table ASIA: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
      • Table ASIA: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
    • ROW
      • Table ROW: CELL SURFACE MARKERS MARKET, BY PRODUCT, 2016–2023 (USD MILLION)
      • Table ROW: CELL SURFACE MARKER ANTIBODIES MARKET, BY SOURCE, 2016–2023 (USD MILLION)
      • Table ROW: CELL SURFACE MARKERS MARKET, BY CELL TYPE, 2016–2023 (USD MILLION)
      • Table ROW: CELL SURFACE MARKERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • Table ROW: CELL SURFACE MARKERS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: CELL SURFACE MARKERS MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2016–2023 (USD MILLION)
      • Table ROW: CELL SURFACE MARKERS MARKET, BY END USER, 2016–2023 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET RANKING ANALYSIS
    • COMPETITIVE SCENARIO
      • PARTNERSHIPS AND AGREEMENTS (2016–2018)
      • PRODUCT LAUNCHES (2016–2018)
      • ACQUISITIONS (2016–2018)
      • EXPANSIONS (2016–2018)
  • COMPANY PROFILES
    • THERMO FISHER SCIENTIFIC
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BECTON, DICKINSON AND COMPANY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • ABCAM
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • QIAGEN N.V.
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • F. HOFFMAN-LA ROCHE
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIO-RAD LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • MNM VIEW
    • DANAHER CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • GENSCRIPT
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
    • BIOLEGEND
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
    • CELL SIGNALING TECHNOLOGY
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
    • BIO-TECHNE
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
    • MERK KGAA
      • BUSINESS OVERVIEW
      • PRODUCT OFFERINGS
      • RECENT DEVELOPMENTS
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report